Taken together, we suggest that activation of c-Met signaling and subsequent induction of EMT is probably a common feature of prostate cancer cells, xenograft models and clinical prostate cancer specimens exhibiting an increased propensity for lethal progression. Here, MET is linked to prostate carcinoma.